Clinical Trials Directory

Trials / Completed

CompletedNCT01491334

Validation of Transvaginal Tactile Imaging

A Clinical Validation Study With Transvaginal Tactile Imaging

Status
Completed
Phase
Study type
Observational
Enrollment
158 (actual)
Sponsor
Artann Laboratories · Industry
Sex
Female
Age
21 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to validate safety and effectiveness in assessment of the female pelvic floor tissue, and, assess the ability of Vaginal Tactile Imager (VTI) to detect early prolapse conditions and characterize the outcome of reconstructive surgery.

Detailed description

1. The device will detect significant differences in tissue elasticity and anatomy for women with normal pelvic floor versus women with prolapse stage 1. 2. The device will detect significant differences in tissue elasticity and anatomy for patients before and after reconstructive surgery. 3. The device will detect significant differences in tissue elasticity and anatomy among 3 groups of patients with prolapse stages 1, 2 and 3. 4. The device will detect significant differences in tissue elasticity among 3 control groups with normal pelvic floor conditions (nulliparous women at age 21-30, parous women at age 31-40, and postmenopausal women).

Conditions

Timeline

Start date
2011-12-01
Primary completion
2013-09-01
Completion
2013-11-01
First posted
2011-12-14
Last updated
2014-02-25

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01491334. Inclusion in this directory is not an endorsement.